- Home
- IMNM vs KRUS Comparison
IMNM vs KRUS Comparison
Compare IMNM & KRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- KRUS
- Stock Information
- Founded
- IMNM 2006
- KRUS 2008
- Country
- IMNM United States
- KRUS United States
- Employees
- IMNM N/A
- KRUS N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- KRUS Restaurants
- Sector
- IMNM Health Care
- KRUS Consumer Discretionary
- Exchange
- IMNM Nasdaq
- KRUS Nasdaq
- Market Cap
- IMNM 748.3M
- KRUS 791.5M
- IPO Year
- IMNM 2020
- KRUS 2019
- Fundamental
- Price
- IMNM $9.06
- KRUS $65.98
- Analyst Decision
- IMNM Strong Buy
- KRUS Buy
- Analyst Count
- IMNM 5
- KRUS 9
- Target Price
- IMNM $26.40
- KRUS $74.67
- AVG Volume (30 Days)
- IMNM 973.9K
- KRUS 219.0K
- Earning Date
- IMNM 05-12-2025
- KRUS 07-08-2025
- Dividend Yield
- IMNM N/A
- KRUS N/A
- EPS Growth
- IMNM N/A
- KRUS N/A
- EPS
- IMNM N/A
- KRUS N/A
- Revenue
- IMNM $10,938,000.00
- KRUS $258,444,000.00
- Revenue This Year
- IMNM N/A
- KRUS $19.58
- Revenue Next Year
- IMNM $542.22
- KRUS $18.91
- P/E Ratio
- IMNM N/A
- KRUS N/A
- Revenue Growth
- IMNM N/A
- KRUS 21.37
- 52 Week Low
- IMNM $5.15
- KRUS $40.03
- 52 Week High
- IMNM $16.81
- KRUS $110.66
- Technical
- Relative Strength Index (RSI)
- IMNM 61.94
- KRUS 54.98
- Support Level
- IMNM $8.50
- KRUS $64.65
- Resistance Level
- IMNM $9.04
- KRUS $67.62
- Average True Range (ATR)
- IMNM 0.54
- KRUS 2.50
- MACD
- IMNM 0.09
- KRUS -0.30
- Stochastic Oscillator
- IMNM 90.18
- KRUS 37.92
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About KRUS Kura Sushi USA Inc.
Kura Sushi USA Inc is a technology-enabled restaurant concept serving authentic Japanese cuisine through an engaging revolving sushi service model. The company operates a chain of sushi restaurants across the United States serving freshly prepared Japanese cuisine using high-quality ingredients that are free from artificial seasonings, sweeteners, colorings, and preservatives. It offers several dishes, including Dashi Olive Salmon, Tomago, Sweet Shrimp, Tuna, Garlic Tuna Steak, and Salmon, among others.